Filing of Food Additive Petition From Environmental Defense Fund, Breast Cancer Prevention Partners, Center for Food Safety, Environmental Working Group, Tom Neltner, and Maricel Maffini; Request To Amend the Food Additive Regulations To Remove Authorization of Fluorinated Polyethylene; Reopening of the Comment Period; Correction, 60336-60337 [2024-16337]

Download as PDF 60336 Federal Register / Vol. 89, No. 143 / Thursday, July 25, 2024 / Proposed Rules 12 CFR Part 741 Bank deposit insurance, Credit, Credit unions, Reporting and recordkeeping requirements. By the National Credit Union Administration Board, this 18th day of July 2024. Melane Conyers-Ausbrooks, Secretary of the Board. For the reasons stated in the preamble, the NCUA Board proposes to amend 12 CFR parts 701 and 741 as follows: PART 701—ORGANIZATION AND OPERATION OF FEDERAL CREDIT UNION 1. The authority citation for part 701 continues to read as follows: ■ Authority: 12 U.S.C. 1752(5), 1755, 1756, 1757, 1758, 1759, 1761a, 1761b, 1766, 1767, 1782, 1784, 1785, 1786, 1787, 1788, 1789. Section 701.6 is also authorized by 15 U.S.C. 3717. Section 701.31 is also authorized by 15 U.S.C. 1601 et seq.; 42 U.S.C. 1981 and 3601– 3610. Section 701.35 is also authorized by 42 U.S.C. 4311–4312. 2. Amend § 701.4 by revising paragraph (b)(3) and adding paragraph (e) to read as follows: ■ § 701.4 General authorities and duties of Federal credit union directors. ddrumheller on DSK120RN23PROD with PROPOSALS1 * * * * * (b) * * * (3) At the time of election or appointment, or within a reasonable time thereafter, not to exceed six months, have at least a working familiarity with, and to ask, as appropriate, substantive questions of management and the internal and external auditors of: (i) Basic finance and accounting practices, including the ability to read and understand the Federal credit union’s balance sheet and income statement; and (ii) The Federal credit union’s succession plan established pursuant to paragraph (e) of this section. * * * * * (e) Succession planning requirements—(1) General. A Federal credit union must establish a written succession plan as provided in this paragraph that is approved by the board of directors and consistent with the credit union’s size and complexity. In evaluating whether a succession plan meets the requirements of this paragraph, the NCUA will consider the size of the Federal credit union, as well as the complexity and risk of its operations. (2) Covered positions. The succession plan shall, at a minimum, cover the VerDate Sep<11>2014 17:40 Jul 24, 2024 Jkt 262001 following positions, or their equivalent if the Federal credit union has adopted different position titles: (i) Members of the board of directors; (ii) Members of the supervisory committee; (iii) Members of the credit committee, where such a committee is provided for in the Federal credit union’s bylaws and is involved daily in the review of loans; (iv) Loan officers, where provided for in the Federal credit union’s bylaws in lieu of a credit committee and the loan officers are involved daily in the review of loans; (v) Management officials and assistant management officials, as those terms are defined in appendix A, if provided for in the Federal credit union’s bylaws; and (vi) The Federal credit union’s chief executive officer (typically this individual holds the title of president or treasurer/manager), any assistant chief executive officer (for example, any assistant president, any vice president, or any assistant treasurer/manager), the chief financial officer (controller), and any other personnel the board of directors deems critical given the Federal credit union’s size, complexity, or risk of operations. This includes new positions that may be required due to planned changes in operations, supervisory landscape, or corporate structure. (3) Contents of succession plan. The succession plan must, at minimum, contain the following information regarding each of the positions covered under paragraph (e)(2) of this section: (i) The title for each covered position and the expiration of the incumbent’s term (if serving in a term-limited capacity) or other anticipated vacancy date (such as the incumbent’s retirement eligibility date or announced departure date). (ii) The Federal credit union’s plan for temporarily and permanently filling vacancies for each of the positions, including vacancies due to unexpected circumstances. (iii) The Federal credit union’s strategy for recruiting candidates with the potential to assume each of the positions. The strategy must consider how the selection and diversity among the employees covered by the succession plan collectively and individually promotes the safe and sound operation of the Federal credit union. (4) Board responsibilities. The board of directors must: (i) Approve a written succession plan that meets the requirements of paragraphs (e)(2) and (3) of this section; and PO 00000 Frm 00008 Fmt 4702 Sfmt 4702 (ii) Review, and update as necessary, the succession plan in accordance with a schedule established by the board of directors but no less than annually. (5) Adherence to plan. The board of directors shall approve and document in its meeting minutes the rationale for substantive deviations from its approved succession plan. PART 741—REQUIREMENTS FOR INSURANCE 3. The authority citation for part 741 continues to read as follows: ■ Authority: 12 U.S.C. 1757, 1766(a), 1781– 1790, and 1790d; 31 U.S.C. 3717. ■ 4. Add § 741.228 to read as follows: § 741.228 Succession planning. Any credit union that is insured pursuant to title II of the Act must adhere to the requirements in § 701.4(b)(3) and (e) of this chapter, to the extent these regulatory provisions do not conflict with an applicable State requirement. [FR Doc. 2024–16227 Filed 7–24–24; 8:45 am] BILLING CODE 7535–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 177 [Docket No. FDA–2024–F–1912] Filing of Food Additive Petition From Environmental Defense Fund, Breast Cancer Prevention Partners, Center for Food Safety, Environmental Working Group, Tom Neltner, and Maricel Maffini; Request To Amend the Food Additive Regulations To Remove Authorization of Fluorinated Polyethylene; Reopening of the Comment Period; Correction AGENCY: Food and Drug Administration, HHS. Notification of petition, reopening of the comment period; correction. ACTION: The Food and Drug Administration (FDA or we) is reopening the comment period for the notification of petition, published in the Federal Register of April 26, 2024, announcing that we have filed a food additive petition, submitted by Environmental Defense Fund, et al., proposing that the food additive regulations be amended to remove fluorinated polyethylene. FDA is reopening the comment period to add the food additive petition to the docket. SUMMARY: E:\FR\FM\25JYP1.SGM 25JYP1 Federal Register / Vol. 89, No. 143 / Thursday, July 25, 2024 / Proposed Rules FDA is also making a correction to the filing notice. DATES: FDA is reopening the comment period on the notification of petition published in the Federal Register of April 26, 2024 (89 FR 32386). Either electronic or written comments must be submitted by September 23, 2024. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. The https:// www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of September 23, 2024. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are received on or before that date. Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). ddrumheller on DSK120RN23PROD with PROPOSALS1 Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ VerDate Sep<11>2014 17:40 Jul 24, 2024 Jkt 262001 Instructions: All submissions received must include the Docket No. FDA– 2024–F–1912 for ‘‘Filing of Food Additive Petition From Environmental Defense Fund, Breast Cancer Prevention Partners, Center for Food Safety, Environmental Working Group, Tom Neltner, and Maricel Maffini; Request To Amend the Food Additive Regulations To Remove Authorization of Fluorinated Polyethylene; Reopening of the Comment Period.’’ Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240–402–7500. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ We will review this copy, including the claimed confidential information, in our consideration of comments. The second copy, which will have the claimed confidential information redacted/ blacked out, will be available for public viewing and posted on https:// www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https:// www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240–402–7500. PO 00000 Frm 00009 Fmt 4702 Sfmt 4702 60337 FOR FURTHER INFORMATION CONTACT: Lillian Mawby, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 301–796–4041. SUPPLEMENTARY INFORMATION: In the Federal Register of April 26, 2024 (89 FR 32386), FDA published a notification of filing of a food additive petition (FAP 3B4837), submitted by Environmental Defense Fund, Breast Cancer Prevention Partners, Center for Food Safety, Environmental Working Group, Tom Neltner, and Maricel Maffini, c/o Maricel Maffini, Frederick, MD 21701. The petition proposes that FDA revoke § 177.1615 (21 CFR 177.1615, ‘‘Polyethylene, fluorinated’’). Interested persons were originally given until June 25, 2024, to comment. Following publication of the filing notice in the Federal Register of April 26, 2024, FDA was alerted that FAP 3B4837 was not uploaded to the docket, which did not allow respondents the ability to view the FAP when the notice was published in the Federal Register. Therefore, we are reopening the comment period for 60 days (which corresponds to the amount of time that the petition was missing from the docket) to allow for interested parties to view the FAP posted to the docket. Correction In the Federal Register of Friday, April 26, 2024 (89 FR 32886), in FR Doc. 2024–09027, on page 32387, in the second column in the paragraph under Section II. ‘‘Request To Repeal 21 CFR part 177.1615,’’ correct the second sentence to read: ‘‘Specifically, the petitioners state that the fluorinated polyethylene manufactured consistent with § 177.1615 can produce per- and poly-fluorinated alkyl substances that can migrate to food and, therefore, are not safe pursuant to section 409(c)(5) of the FD&C Act (21 U.S.C. 348(c)(5)).’’ We are correcting the sentence to delete the word ‘‘polymeric.’’ Dated: July 22, 2024. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2024–16337 Filed 7–24–24; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF VETERANS AFFAIRS 38 CFR Part 1 RIN 2900–AS11 Privacy Act of 1974; Implementation Department of Veterans Affairs. Proposed rule. AGENCY: ACTION: E:\FR\FM\25JYP1.SGM 25JYP1

Agencies

[Federal Register Volume 89, Number 143 (Thursday, July 25, 2024)]
[Proposed Rules]
[Pages 60336-60337]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16337]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 177

[Docket No. FDA-2024-F-1912]


Filing of Food Additive Petition From Environmental Defense Fund, 
Breast Cancer Prevention Partners, Center for Food Safety, 
Environmental Working Group, Tom Neltner, and Maricel Maffini; Request 
To Amend the Food Additive Regulations To Remove Authorization of 
Fluorinated Polyethylene; Reopening of the Comment Period; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notification of petition, reopening of the comment period; 
correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is reopening the 
comment period for the notification of petition, published in the 
Federal Register of April 26, 2024, announcing that we have filed a 
food additive petition, submitted by Environmental Defense Fund, et 
al., proposing that the food additive regulations be amended to remove 
fluorinated polyethylene. FDA is reopening the comment period to add 
the food additive petition to the docket.

[[Page 60337]]

FDA is also making a correction to the filing notice.

DATES: FDA is reopening the comment period on the notification of 
petition published in the Federal Register of April 26, 2024 (89 FR 
32386). Either electronic or written comments must be submitted by 
September 23, 2024.

ADDRESSES: You may submit comments as follows. Please note that late, 
untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 
11:59 p.m. Eastern Time at the end of September 23, 2024. Comments 
received by mail/hand delivery/courier (for written/paper submissions) 
will be considered timely if they are received on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2024-F-1912 for ``Filing of Food Additive Petition From 
Environmental Defense Fund, Breast Cancer Prevention Partners, Center 
for Food Safety, Environmental Working Group, Tom Neltner, and Maricel 
Maffini; Request To Amend the Food Additive Regulations To Remove 
Authorization of Fluorinated Polyethylene; Reopening of the Comment 
Period.'' Received comments, those filed in a timely manner (see 
ADDRESSES), will be placed in the docket and, except for those 
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. 
and 4 p.m., Monday through Friday, 240-402-7500.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review 
this copy, including the claimed confidential information, in our 
consideration of comments. The second copy, which will have the claimed 
confidential information redacted/blacked out, will be available for 
public viewing and posted on https://www.regulations.gov. Submit both 
copies to the Dockets Management Staff. If you do not wish your name 
and contact information to be made publicly available, you can provide 
this information on the cover sheet and not in the body of your 
comments and you must identify this information as ``confidential.'' 
Any information marked as ``confidential'' will not be disclosed except 
in accordance with 21 CFR 10.20 and other applicable disclosure law. 
For more information about FDA's posting of comments to public dockets, 
see 80 FR 56469, September 18, 2015, or access the information at: 
https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852, 240-402-7500.

FOR FURTHER INFORMATION CONTACT: Lillian Mawby, Center for Food Safety 
and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., 
College Park, MD 20740, 301-796-4041.

SUPPLEMENTARY INFORMATION: In the Federal Register of April 26, 2024 
(89 FR 32386), FDA published a notification of filing of a food 
additive petition (FAP 3B4837), submitted by Environmental Defense 
Fund, Breast Cancer Prevention Partners, Center for Food Safety, 
Environmental Working Group, Tom Neltner, and Maricel Maffini, c/o 
Maricel Maffini, Frederick, MD 21701. The petition proposes that FDA 
revoke Sec.  177.1615 (21 CFR 177.1615, ``Polyethylene, fluorinated''). 
Interested persons were originally given until June 25, 2024, to 
comment.
    Following publication of the filing notice in the Federal Register 
of April 26, 2024, FDA was alerted that FAP 3B4837 was not uploaded to 
the docket, which did not allow respondents the ability to view the FAP 
when the notice was published in the Federal Register. Therefore, we 
are reopening the comment period for 60 days (which corresponds to the 
amount of time that the petition was missing from the docket) to allow 
for interested parties to view the FAP posted to the docket.

Correction

    In the Federal Register of Friday, April 26, 2024 (89 FR 32886), in 
FR Doc. 2024-09027, on page 32387, in the second column in the 
paragraph under Section II. ``Request To Repeal 21 CFR part 177.1615,'' 
correct the second sentence to read: ``Specifically, the petitioners 
state that the fluorinated polyethylene manufactured consistent with 
Sec.  177.1615 can produce per- and poly-fluorinated alkyl substances 
that can migrate to food and, therefore, are not safe pursuant to 
section 409(c)(5) of the FD&C Act (21 U.S.C. 348(c)(5)).''
    We are correcting the sentence to delete the word ``polymeric.''

    Dated: July 22, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-16337 Filed 7-24-24; 8:45 am]
BILLING CODE 4164-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.